177 related articles for article (PubMed ID: 17367590)
1. Is there genetic polymorphism evidence for individual human sensitivity to opiates?
Nagashima M; Katoh R; Sato Y; Tagami M; Kasai S; Ikeda K
Curr Pain Headache Rep; 2007 Apr; 11(2):115-23. PubMed ID: 17367590
[TBL] [Abstract][Full Text] [Related]
2. How individual sensitivity to opiates can be predicted by gene analyses.
Ikeda K; Ide S; Han W; Hayashida M; Uhl GR; Sora I
Trends Pharmacol Sci; 2005 Jun; 26(6):311-7. PubMed ID: 15925706
[TBL] [Abstract][Full Text] [Related]
3. Mu opioid receptors on primary afferent nav1.8 neurons contribute to opiate-induced analgesia: insight from conditional knockout mice.
Weibel R; Reiss D; Karchewski L; Gardon O; Matifas A; Filliol D; Becker JA; Wood JN; Kieffer BL; Gaveriaux-Ruff C
PLoS One; 2013; 8(9):e74706. PubMed ID: 24069332
[TBL] [Abstract][Full Text] [Related]
4. Are mu-opioid receptor polymorphisms important for clinical opioid therapy?
Lötsch J; Geisslinger G
Trends Mol Med; 2005 Feb; 11(2):82-9. PubMed ID: 15694871
[TBL] [Abstract][Full Text] [Related]
5. [Individual differences in analgesic effects of narcotics].
Ide S; Kasai S; Ikeda K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):43-8. PubMed ID: 18411709
[TBL] [Abstract][Full Text] [Related]
6. The untranslated region of (mu)-opioid receptor mRNA contributes to reduced opioid sensitivity in CXBK mice.
Ikeda K; Kobayashi T; Ichikawa T; Kumanishi T; Niki H; Yano R
J Neurosci; 2001 Feb; 21(4):1334-9. PubMed ID: 11160404
[TBL] [Abstract][Full Text] [Related]
7. Intracisternal A-particle element in the 3' noncoding region of the mu-opioid receptor gene in CXBK mice: a new genetic mechanism underlying differences in opioid sensitivity.
Han W; Kasai S; Hata H; Takahashi T; Takamatsu Y; Yamamoto H; Uhl GR; Sora I; Ikeda K
Pharmacogenet Genomics; 2006 Jun; 16(6):451-60. PubMed ID: 16708053
[TBL] [Abstract][Full Text] [Related]
8. Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene,
Liu S; Kang WJ; Abrimian A; Xu J; Cartegni L; Majumdar S; Hesketh P; Bekker A; Pan YX
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680158
[TBL] [Abstract][Full Text] [Related]
9. μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia.
Sun J; Chen SR; Chen H; Pan HL
J Physiol; 2019 Mar; 597(6):1661-1675. PubMed ID: 30578671
[TBL] [Abstract][Full Text] [Related]
10. Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?
Lötsch J; Zimmermann M; Darimont J; Marx C; Dudziak R; Skarke C; Geisslinger G
Anesthesiology; 2002 Oct; 97(4):814-9. PubMed ID: 12357145
[TBL] [Abstract][Full Text] [Related]
11. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.
Klepstad P; Rakvåg TT; Kaasa S; Holthe M; Dale O; Borchgrevink PC; Baar C; Vikan T; Krokan HE; Skorpen F
Acta Anaesthesiol Scand; 2004 Nov; 48(10):1232-9. PubMed ID: 15504181
[TBL] [Abstract][Full Text] [Related]
12. The genetic influences on oxycodone response characteristics in human experimental pain.
Olesen AE; Sato H; Nielsen LM; Staahl C; Droney J; Gretton S; Branford R; Drewes AM; Arendt-Nielsen L; Riley J; Ross J
Fundam Clin Pharmacol; 2015 Aug; 29(4):417-25. PubMed ID: 26042474
[TBL] [Abstract][Full Text] [Related]
13. The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses.
Uhl GR; Sora I; Wang Z
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7752-5. PubMed ID: 10393893
[TBL] [Abstract][Full Text] [Related]
14. Combined analysis of circulating β-endorphin with gene polymorphisms in OPRM1, CACNAD2 and ABCB1 reveals correlation with pain, opioid sensitivity and opioid-related side effects.
Rhodin A; Grönbladh A; Ginya H; Nilsson KW; Rosenblad A; Zhou Q; Enlund M; Hallberg M; Gordh T; Nyberg F
Mol Brain; 2013 Feb; 6():8. PubMed ID: 23402298
[TBL] [Abstract][Full Text] [Related]
15. Pain polymorphisms and opioids: An evidence based review.
Vieira CMP; Fragoso RM; Pereira D; Medeiros R
Mol Med Rep; 2019 Mar; 19(3):1423-1434. PubMed ID: 30592275
[TBL] [Abstract][Full Text] [Related]
16. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
17. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.
Reyes-Gibby CC; Shete S; Rakvåg T; Bhat SV; Skorpen F; Bruera E; Kaasa S; Klepstad P
Pain; 2007 Jul; 130(1-2):25-30. PubMed ID: 17156920
[TBL] [Abstract][Full Text] [Related]
18. Effect of KEPI (Ppp1r14c) deletion on morphine analgesia and tolerance in mice of different genetic backgrounds: when a knockout is near a relevant quantitative trait locus.
Drgonova J; Zimonjic DB; Hall FS; Uhl GR
Neuroscience; 2010 Feb; 165(3):882-95. PubMed ID: 19819304
[TBL] [Abstract][Full Text] [Related]
19. Genetic Influences of OPRM1, OPRD1 and COMT on Morphine Analgesia in a Multi-Modal, Multi-Tissue Human Experimental Pain Model.
Nielsen LM; Christrup LL; Sato H; Drewes AM; Olesen AE
Basic Clin Pharmacol Toxicol; 2017 Jul; 121(1):6-12. PubMed ID: 28084056
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response.
Romberg RR; Olofsen E; Bijl H; Taschner PE; Teppema LJ; Sarton EY; van Kleef JW; Dahan A
Anesthesiology; 2005 Mar; 102(3):522-30. PubMed ID: 15731588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]